Global Multiple System Atrophy Market to Reach US$ 212.1 Million by 2033, Propelled by the Rising Prevalence of Neurogenerative Disorders

April 12, 2023 | Healthcare

The latest report by IMARC, titled “Multiple System Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast,” finds that the global multiple system atrophy market size reached US$ 128 Million by 2022. Multiple system atrophy (MSA) is a rare, progressive neurodegenerative disorder that affects movement and the autonomic nervous system, as well as the motor system. Tremors, muscle stiffness, difficulty with movement and coordination, loss of balance, autonomic dysfunction (blood pressure and heart rate regulation, bladder and bowel control, and temperature regulation), and difficulty speaking and swallowing are some of the common symptoms of MSA. It usually requires a combination of clinical, neurological, and imaging evaluations, such as magnetic resonance imaging (MRI) and positron emission tomography (PET). A clinical evaluation includes a detailed medical history, physical examination, and an assessment of the patient's motor function, balance, speech, and cognition.


Global Multiple System Atrophy Market Trends:

The rising prevalence of neurogenerative disorders, such as Parkinson's disease, Alzheimer's disease, and MSA, are among the key factors driving the market growth. Moreover, various advancements in diagnostic tools, including imaging studies and biomarker testing, that help to improve the accuracy and timeliness of MSA diagnosis are favoring the market growth. Apart from this, the introduction of advanced imaging technologies and gene editing to improve the accuracy and timeliness of MSA diagnosis is providing an impetus to the market growth. In line with this, the shifting preferences toward non-pharmacological approaches, such as physiotherapy, occupational therapy, and speech therapy, to improve the quality of life for people with MSA is acting as another growth-inducing factor. Furthermore, several companies and academic institutions are investing in the development of new therapies and management strategies, which in turn is propelling the market growth. Other factors, including extensive research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives offering pathways for the development and approval of new therapies, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market value to reach US$ 212.1 Billion by 2033, expanding at a CAGR of 4.50% during the forecast period (2022-2033). 


Market Summary:

  • Region-wise, the market has been classified into the United States, EU5 (Germany, France, the United Kingdom, Italy, and Spain), and Japan. The United States has the largest patient population for multiple system atrophy and also represents the largest market for its treatment among the seven major markets.
  • This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for multiple system atrophy.
  • The study also offers a thorough overview of the treatment practices for multiple system atrophy, the share of specific therapies, and the performance of key market players.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Multiple System Atrophy Market to Reach US$ 212.1 Million by 2033, Propelled by the Rising Prevalence of Neurogenerative Disorders
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More